title: Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma in China: a SELDI-TOF-MS study.
abstract: Hepatocellular carcinoma (HCC) is one of the most common malignancies with high mortality, but its underlying molecular mechanisms remain not well understood. High-throughput, proteomic techniques targeting unique biological molecules may provide novel insights into HCC pathogenesis and prognosis. In this study, we systemically investigated tissue biomarkers of HCC by using surface-enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technique. Proteomic spectra were generated from fresh tissues (26 HCC and 18 control cirrhotic liver) and analyzed by using Biomarker Wizard System. A total of 16 differential proteomic peaks were detected between HCC and cirrhotic liver tissues, and 11 between moderately and highly differentiated HCCs. The expression pattern of one proteomic peak was validated by immunohistochemistry. These molecules are potential candidate biomarkers for early diagnosis of and targeted therapy for HCC.
authors.affiliation: Departments of Pathology and Laboratory Medicine, 306 Hospital, Beijing, China. zhangjz55@hotmail.com
authors.forename: Jianzhong
authors.initials: J
authors.lastname: Zhang
authors.forename: Dong
authors.initials: D
authors.lastname: Li
authors.forename: Yanhua
authors.initials: Y
authors.lastname: Zheng
authors.forename: Yan
authors.initials: Y
authors.lastname: Cui
authors.forename: Kai
authors.initials: K
authors.lastname: Feng
authors.forename: Jinlian
authors.initials: J
authors.lastname: Zhou
authors.forename: Jihua
authors.initials: J
authors.lastname: Wu
references.citation: Am J Pathol. 1999 Sep;155(3):703-10
references.pmid: 10487827
references.citation: Electrophoresis. 2000 Jun;21(11):2105-14
references.pmid: 10892721
references.citation: World J Gastroenterol. 2002 Apr;8(2):193-9
references.pmid: 11925590
references.citation: Cell. 1993 Aug 27;74(4):609-19
references.pmid: 8358790
references.citation: Lancet. 2002 Feb 16;359(9306):572-7
references.pmid: 11867112
references.citation: J Formos Med Assoc. 1993 Oct;92(10):866-70
references.pmid: 7511953
references.citation: Gastroenterology. 2005 Jul;129(1):66-73
references.pmid: 16012935
references.citation: Cancer Res. 1994 Jun 15;54(12):3107-10
references.pmid: 8205525
references.citation: Gastroenterology. 2006 May;130(6):1670-8
references.pmid: 16697731
references.citation: Hepatology. 2005 Jan;41(1):40-7
references.pmid: 15690480
references.citation: Electrophoresis. 1995 Jun;16(6):1034-59
references.pmid: 7498127
references.citation: Br J Cancer. 2006 Jun 19;94(12):1898-905
references.pmid: 16755300
references.citation: J Neurochem. 2005 Dec;95(5):1461-71
references.pmid: 16313519
references.citation: Proteomics. 2006 Jun;6(11):3426-35
references.pmid: 16673437
references.citation: Mass Spectrom Rev. 2004 Jan-Feb;23(1):34-44
references.pmid: 14625891
references.citation: Arch Pathol Lab Med. 2002 Dec;126(12):1518-26
references.pmid: 12456215
references.citation: Electrophoresis. 1999 Apr-May;20(4-5):743-8
references.pmid: 10344243
references.citation: Mod Pathol. 2004 Jun;17(6):670-8
references.pmid: 15098007
references.citation: Nat Genet. 2002 Aug;31(4):339-46
references.pmid: 12149612
references.citation: J Clin Endocrinol Metab. 1993 Feb;76(2):378-83
references.pmid: 7679399
references.citation: Cancer Res. 2004 Sep 1;64(17):5929-33
references.pmid: 15342369
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12343-8
references.pmid: 14523236
references.citation: Cancer Res. 2002 Mar 15;62(6):1868-75
references.pmid: 11912167
references.citation: Cancer Res. 1995 Oct 1;55(19):4471-8
references.pmid: 7671262
references.citation: Dig Liver Dis. 2006 Nov;38(11):854-9
references.pmid: 16782417
references.citation: Mol Cell Proteomics. 2003 Jul;2(7):443-52
references.pmid: 12824440
references.citation: J Proteome Res. 2005 Sep-Oct;4(5):1799-804
references.pmid: 16212435
references.citation: Proteomics. 2006 Apr;6(8):2600-8
references.pmid: 16502466